Literature DB >> 9132486

Hereditary spinal neurofibromatosis: a rare form of NF1?

M Poyhonen1, E L Leisti, S Kytölä, J Leisti.   

Abstract

We describe a family in which seven members in three generations were affected with a rare spinal neurofibromatosis. The affected adults showed, at the ages of 32, 37, 38, and 61, respectively, multiple spinal neurofibromas symmetrically affecting all spinal roots. Two patients were operated on for histopathologically proven cervical spinal neurofibromas. All patients had café au lait spots, one had several freckles in the axillary area, and two had possible dermal neurofibromas, but iris Lisch-nodules were not present. Other signs of neurofibromatosis types 1 and 2 were absent. A linkage study of the family suggested close linkage to the NF1 locus and excluded it from the NF2 locus. The DNA analysis of histopathologically verified spinal neurofibromas in two patients showed no evidence of LOH at 17q11.2. The findings in the present family, together with those in a family previously described, suggest a clinically distinct form of neurofibromatosis with extensive spinal neurofibromas and café au lait macules, which may be allelic to the NF1 gene.

Entities:  

Mesh:

Year:  1997        PMID: 9132486      PMCID: PMC1050889          DOI: 10.1136/jmg.34.3.184

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  The 1993-94 Généthon human genetic linkage map.

Authors:  G Gyapay; J Morissette; A Vignal; C Dib; C Fizames; P Millasseau; S Marc; G Bernardi; M Lathrop; J Weissenbach
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

2.  Highly polymorphic dinucleotide repeat at the NF2 gene.

Authors:  D Bourn; T Strachan
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

3.  Spinal MR findings in neurofibromatosis types 1 and 2.

Authors:  J C Egelhoff; D J Bates; J S Ross; A D Rothner; B H Cohen
Journal:  AJNR Am J Neuroradiol       Date:  1992 Jul-Aug       Impact factor: 3.825

4.  A genetic study of neurofibromatosis type 1 (NF1) in south-western Ontario. II. A PCR based approach to molecular and prenatal diagnosis using linkage.

Authors:  D I Rodenhiser; P J Ainsworth; M B Coulter-Mackie; S M Singh; J H Jung
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

5.  Long-term outcome after removal of spinal neurofibroma.

Authors:  M T Seppälä; M J Haltia; R J Sankila; J E Jääskeläinen; O Heiskanen
Journal:  J Neurosurg       Date:  1995-04       Impact factor: 5.115

6.  Autosomal dominant multiple café-au-lait spots and neurofibromatosis-1: evidence of non-linkage.

Authors:  J Charrow; R Listernick; K Ward
Journal:  Am J Med Genet       Date:  1993-03-01

7.  Two CA/GT repeat polymorphisms in intron 27 of the human neurofibromatosis (NF1) gene.

Authors:  C Lázaro; A Gaona; X Estivill
Journal:  Hum Genet       Date:  1994-03       Impact factor: 4.132

Review 8.  Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors.

Authors:  D N Louis; V Ramesh; J F Gusella
Journal:  Brain Pathol       Date:  1995-04       Impact factor: 6.508

Review 9.  Neurofibromatosis type 1: pathology, clinical features and molecular genetics.

Authors:  A von Deimling; W Krone; A G Menon
Journal:  Brain Pathol       Date:  1995-04       Impact factor: 6.508

10.  Familial spinal neurofibromatosis: clinical and DNA linkage analysis.

Authors:  S M Pulst; V M Riccardi; P Fain; J R Korenberg
Journal:  Neurology       Date:  1991-12       Impact factor: 9.910

View more
  8 in total

1.  Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion.

Authors:  Antonio Pizzuti; Irene Bottillo; Francesca Inzana; Valentina Lanari; Francesca Buttarelli; Isabella Torrente; Anna Teresa Giallonardo; Alessandro De Luca; Bruno Dallapiccola
Journal:  Neurogenetics       Date:  2011-03-02       Impact factor: 2.660

Review 2.  Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis.

Authors:  Sebastian Laycock-van Spyk; Nick Thomas; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2011-10       Impact factor: 4.639

3.  Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene.

Authors:  D Kaufmann; R Müller; B Bartelt; M Wolf; K Kunzi-Rapp; C O Hanemann; R Fahsold; C Hein; W Vogel; G Assum
Journal:  Am J Hum Genet       Date:  2001-10-18       Impact factor: 11.025

4.  An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation.

Authors:  M Upadhyaya; S M Huson; M Davies; N Thomas; N Chuzhanova; S Giovannini; D G Evans; E Howard; B Kerr; S Griffiths; C Consoli; L Side; D Adams; M Pierpont; R Hachen; A Barnicoat; H Li; P Wallace; J P Van Biervliet; D Stevenson; D Viskochil; D Baralle; E Haan; V Riccardi; P Turnpenny; C Lazaro; L Messiaen
Journal:  Am J Hum Genet       Date:  2006-12-08       Impact factor: 11.025

5.  A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene.

Authors:  E Ars; H Kruyer; A Gaona; P Casquero; J Rosell; V Volpini; E Serra; C Lázaro; X Estivill
Journal:  Am J Hum Genet       Date:  1998-04       Impact factor: 11.025

6.  Neurofibromatosis type I: spinal neoplasia without symptoms.

Authors:  Sheffali Gulati; Surbhi Leekha; Arun K Gupta; Veena Kalra
Journal:  Indian J Pediatr       Date:  2004-09       Impact factor: 1.967

7.  The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas.

Authors:  Meena Upadhyaya; Gill Spurlock; Lan Kluwe; Nadia Chuzhanova; Emma Bennett; Nick Thomas; Abhijit Guha; Victor Mautner
Journal:  Neurogenetics       Date:  2009-02-17       Impact factor: 2.660

8.  Severe High Cervical Cord Compression Due to Large Bilateral Neurofibromas in a Patient With Neurofibromatosis Type 1: A Case Report and Review of Literature.

Authors:  Morteza Sadeh; Hamad Farhat
Journal:  Cureus       Date:  2022-07-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.